Nalaganje...
Ondansetron Exposure Changes in a Pregnant Woman
Pregnancy results in many physiologic changes that can alter the pharmacokinetic profiles of medications used during pregnancy. One of the primary factors leading to these pharmacokinetic changes is altered activity of drug-metabolizing enzymes. Ondansetron is a substrate of cytochrome P450 (CYP) 3A...
Shranjeno v:
| izdano v: | Pharmacotherapy |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5738660/ https://ncbi.nlm.nih.gov/pubmed/27374186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1796 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|